| Application no. and date | 18816685.4 (espacenet) (Federated) (European Patent Register), 20180613 | | Patent/reg. no. and date | DK/EP 3638243, 20240807 | | Publication date | 20200422 | | Priority no. and date | US 201762519725 P, 20170614, US 201862679210 P, 20180601 | | EP pub. no. and date |
EP 3638243 20200422 | | Effective date | | | Applicant/owner | Celgene Corporation, Route 206 & Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | P85299DK01 | | Inventor | GALE, Robert, 2316 Donella Circle
Los Angeles
CA 90077, US,
LAADEM, Abderrahmane, 12 Matthews Farm Rd.
Belle Mead
NJ 08502, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61K 38/17 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , C07K 14/495 (2006.01) | | Title | FREMGANGSMÅDER TIL BEHANDLING AF MYELOPROLIFERATIV NEOPLASMA-FORBUNDET MYELOFIBROSE OG ANÆMI | | Int. application no. | US2018037213 | | Int. publication no. | WO2018231905 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
